Printer Friendly

Disturbance of Inorganic Phosphate Metabolism in Diabetes Mellitus: Its Relevance to the Pathogenesis of Diabetic Retinopathy.

Early in the progression of diabetes, a paradoxical metabolic imbalance in inorganic phosphate ([P.sub.i]) occurs that may lead to reduced high energy phosphate and tissue hypoxia. These changes take place in the cells and tissues in which the entry of glucose is not controlled by insulin, particularly in poorly regulated diabetes patients in whom long-term vascular complications are more likely. Various conditions are involved in this disturbance in [P.sub.i]. First, the homeostatic function of the kidneys is suboptimal in diabetes, because elevated blood glucose concentrations depolarize the brush border membrane for [P.sub.i] reabsorption and lead to lack of intracellular phosphate and hyperphosphaturia. Second, during hyperglycemic-hyperinsulinemic intervals, high amounts of glucose enter muscle and fat tissues, which are insulin sensitive. Intracellular glucose is metabolized by phosphorylation, which leads to a reduction in plasma [P.sub.i], and subsequent deleterious effects on glucose metabolism in insulin insensitive tissues. Hypophosphatemia is closely related to a decrease in adenosine triphosphate (ATP) in the aging process and in uremia. Any interruption of optimal ATP production might lead to cell injury and possible cell death, and evidence will be provided herein that such cell death does occur in diabetic retinopathy. Based on this information, the mechanism of capillary microaneurysms formation in diabetic retinopathy and the pathogenesis of diabetic retinopathy must be reevaluated.

1. Introduction

Diabetic retinopathy is a leading cause of visual impairment in adults. In proliferative diabetic retinopathy, ischemia-induced pathologic growth of new blood vessels often causes catastrophic loss of vision. The pathogenesis of many of the various components of diabetic retinopathy remains poorly understood, but it is generally accepted that the development of retinopathy is multifactorial and that hyperglycemia is a very important constituent. Although large-scale population studies (Diabetes Control and Complication Trial (DCCT) [1] and United Kingdom Prospective Diabetes Study (UKPDS)) [2] have clearly shown the significance of preventative measures by patients with the guidance of their physicians, many patients still develop severe retinopathy despite considerable preventative efforts, and others who made little or no effort escape severe vascular sequelae [3]. Similarly, detailed statistical calculations of the DCCT study have revealed that the duration of diabetes (glycemic exposure) and HbA1c explained only 11% of the variation in retinopathy risk, suggesting that the remaining 89% of the risk variation is due to other factors [4]. These observations indicate that glucose or a factor closely related to glucose metabolism, such as intracellular phosphate, may be a causative factor. We have researched this concept for a number of years [5-8]. While low and high uncontrolled blood sugars give rise to easily recognizable clinical symptoms, low and high plasma inorganic phosphate remains unrecognizable or presents vague and general symptoms. Hypophosphatemia is strongly related to a decrease in intracellular adenosine triphosphate (ATP) in the aging process and in uremia. Lichtman et al. [9] conducted a detailed study of the relationship between hypophosphatemia and erythrocyte ATP in a patient with chronic renal disease and uremia who was under treatment with a low-protein diet, hemodialysis, and aluminum hydroxide gel. Erythrocyte ATP was markedly reduced during the period of hypophosphatemia. Discontinuation of aluminum hydroxide gel completely reversed the biochemical blood abnormality and restored erythrocyte ATP, and the correlation of serum inorganic phosphorous and erythrocyte ATP was close (correlation coefficient, r = 0.95, P < 0.001). It was suggested that similar reduction in ATP may occur in many other somatic cells.

2. The Change of Diabetes from a Metabolic Disease to a Major Cardiovascular Disorder

The advent of insulin treatment in the early 1920s dramatically changed the prognosis for diabetes patients, particularly young, insulin-dependent diabetes, but the resultant increase in longevity was confounded by an unforeseen and immense problem--cardiovascular disorders--which constitutes a significant burden on both diabetic patients and overall medical costs.

In the healthy organism, there is an optimal amount of insulin secreted in response to intake of carbohydrates, and blood sugar and plasma inorganic phosphate ([P.sub.i]) are maintained within narrow physiological ranges for both insulin-sensitive and insulin-insensitive tissues. In the diabetic organism, however, insulin treatment has modified the disease to a unique chronic condition characterized by a cellular glucose metabolism that is seldom in a steady state. In both insulin-dependent (Type 1) and noninsulin-dependent (Type 2) diabetics, abnormally high blood glucose is linked to nonphysiologic variations in plasma insulin content throughout a 24-hour period, sometimes too little, and at other times too much. During hyperglycemic-hyperinsulinemic conditions, high amounts of glucose enter into muscle and fat tissues (insulin-sensitive).

Intracellular glucose is metabolized by phosphorylation which leads to lower levels of plasma Pi and consequent negative effects on glucose metabolism in the insulin-insensitive tissues and the development of long-term cardiovascular sequelae. In addition, the kidneys are the major regulator of Pi homeostasis, a function not optimal in diabetes [6]. In the renal proximal tubular cell, glucose, Pi, and alanine (myoinositol and more), reabsorptions take place as secondary active transport processes with sodium ([Na.sup.+]) as the driving force. The favorable [Na.sup.+] entry results from active extrusion of [Na.sup.+] across the basolateral segment of the proximal tubular cells, energized by ATP hydrolysis and catalyzed by the Na/K-ATPase. Many findings are consistent with the concept that the inhibitory interaction among [Na.sup.+]-dependent transport processes results from shared dependence on the transmembrane electrochemical [Na.sup.+] gradient. Accordingly, the cotransporters with sodium of one solute decrease the electrochemical [Na.sup.+] gradient available to drive fluxes of other cotransporter solutes [10-12]. In this respect, glucose is more potent than Pi in stimulating the uptake of [Na.sup.+] in renal microvillous vesicles [11]. Therefore, elevated blood glucose concentrations depolarize the brush border membrane for Pi and lead to lack of intracellular phosphate and hyperphosphaturia. That this relationship also is applicable to human diabetes has been shown in juvenile diabetic patients. The higher the blood glucose, and therefore the reabsorption rate of glucose, the lower the maximal phosphate reabsorption rate ([T.sub.mPO4]/GFR) [13].

3. Inorganic Phosphate, ATP, and Diabetic Retinopathy

Phosphorus plays a critical role in the storage, transfer, and liberation of energy in the organism as well as in the intermediate metabolism of carbohydrates, fat, and proteins. Inorganic phosphate ([P.sub.i]) is a vital component of DNA and RNA and participates both in glycolysis and oxidative phosphorylation. In glycolysis, [P.sub.i] is a substrate for glyceraldehyde-3-phosphate dehydrogenase and stimulates the activities of hexokinase and phosphofructokinase.

Mitochondria are the power plants of our bodies, and their primary function is to manufacture adenosine triphosphate (ATP), which provides 90-95% of all cellular energy mainly by oxidative phosphorylation [14].

The concentration of plasma [P.sub.i], thereby red cell 2,3-diphosphoglycerate and ATP levels, and oxygen delivery to tissue are closely interrelated in diabetes and other conditions (hyperalimentation and uremia) as has been clearly documented [6, 15-17].

The amount of ATP in the cell is small relative to the amount of energy that the cell needs to perform its normal work. Therefore, ATP must be constantly replenished according to the equation for oxidative metabolism, 3ADP + 3[P.sub.i] + 1/2[O.sub.2] + NADH [right arrow] 3ATP + NAD + [H.sub.2]O, to provide a continuous supply of free energy available [18]. Therefore, it is likely that the combination of an unstable glucose metabolism and deficiencies of major substrates in ATP synthesis ([P.sub.i] and/or oxygen) may lead to lack of intracellular ATP in noninsulin-dependent tissues (such as the endothelium and retina). The interruption of optimal ATP production for any reason might lead to cell injury and possibly cell death.

Herein, we provide evidence that such cell death occurs in human diabetic retinas and possibly in other tissues. Suggestions will be made that retinal microaneurysms likely presuppose three factors: (1) a weakness in vessel wall structures, (2) increased hydrostatic back pressure from distended venous microcirculation, and (3) deficient intracellular ATP/and or hypoxia, all of which may contribute to retinal microaneurysms and could be present in diabetes. Depletion of endothelium and pericytes may obliterate capillaries and result in a resemblance to basement membrane tubes free of these cells, leading to the so-called "acellular capillaries" Other vascular abnormalities may be associated with these lesions, such as thickening of capillary basement membrane, blot hemorrhages, exudates, dilatation and varicosities of capillaries and venules, increased vascular endothelium growth factor (VEGF), and other growth factors that stimulate further vascular permeability and neovascularization.

4. Loss of Intramural Pericytes in Diabetic Retinopathy

Cogan et al. [19] in 1961 described a selective loss of intramural pericytes (IMP) from the retinal capillaries that retained their endothelium, and IMP were replaced by "ghost cells" The authors suggested that these cells were probably involved with control of microcirculatory blood flow and therefore were of significance in the pathogenesis of diabetic retinopathy [20]. In this respect, it is of interest that IMP constrict by application of ATP [21]. Addison et al. [22] found that while IMP degeneration in the presence of intact endothelial cells is a characteristic of diabetic retinopathy, it is not specific for this condition, since similar lesions have been demonstrated in a variety of diseases such as macroglobulinemia, myelomatosis, cyanosis, and polycythemia. However, these investigators agreed that the extent of IMP loss was far less significant in nondiabetic retinopathy. Several pathological studies related to pericytes and endothelium are based on statements. However, statistical analysis was provided by Speiser et al. [23], who carefully studied the eyes of 203 patients (46 with diabetes, 46 with hypertensive arteriosclerotic vascular disease, 27 with chronic lung disease, etc.). Their results showed a specific and highly significant loss of IMP in diabetes, regardless of age, and that such a loss was associated with an increase in ghost cells, shunt vessels, and the number of microaneurysms.

5. Accelerated Endothelial Cell Death and Replacement in Diabetic Retinopathy

Based on electron microscopy of diabetic skeletal capillaries, Vracko first indicated that the thickened basal membrane (BM) in patients with diabetes mellitus exhibited structural characteristics that suggested the accumulation of BM was caused by repeated episodes of endothelium cell death and regeneration [24, 25]. This suggestion was based on the following findings: (1) Lamellation of BM, (2) presence of cell debris between the lamellae, (3) absence of BM thickening between pericytes and endothelial cells, and (4) presence of acellular BM cylinders in skeletal muscle interstitium.

It has been shown that the regenerating capillaries grow within the old, acellular BM tubes and then form a new second layer of BM [26]. The result is a capillary with two lamellas of BM between which cell debris may become trapped. Repetition of endothelium death and regeneration adds successive lamellas of BM and progressively narrows the capillary caliber. Thus, repeated endothelium death and regeneration with excessive thickening of BM may participate in capillary closure in diabetes. The extent of BM thickening can, like the rings in a cross-section of a tree trunk, give some idea about the number of cell generations that have occurred in a specific capillary.

Evidence of accelerated death of retinal microvascular cells in human diabetic retinopathy has been provided by Mizutani et al. [27], who compared the occurrence of cell death in diabetic and nondiabetic individuals with the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) reaction, which detects preferentially apoptotic DNA fragmentation. The TUNEL-positive nuclei were significantly greater in the microvessels of diabetic (13 [+ or -] 12 per one sixth of retina) versus control subjects (1.3 [+ or -] 1.4: P < 0.0016), as were the counts of TUNEL-positive pericytes and endothelial cells (P < 0.006). Neural retinas from both diabetic and nondiabetic subjects were uniformly TUNEL negative.

Also of interest is the study of Martin et al. [28], who found a reduced number of cell generations in fibroblasts in culture from a juvenile diabetic patient, a finding later confirmed in a larger study [29].

Measurements of total basal lamina width in skeletal muscle capillaries are another useful parameter to compare. Many studies have clearly shown that BMs, at least in some anatomical areas in some diabetic patients, are much thicker than in nondiabetics of comparable ages. The findings also showed that thickened and normal BMs are not structurally homogeneous. According to the studies of Vracko [30], this may imply that the rate of cell renewal is accelerated in diabetes, that diabetics are exposed to appropriate cell injuries at a frequency and/or intensity greater than nondiabetic controls, or that the cells of diabetics are exceptionally vulnerable to injury. However, that these findings are related to a factor in the diabetic milieu rather than a hereditary factor is supported by studies of capillary BM in identical twin pairs discordant for Type 1 diabetes in which the BM of the quadriceps muscle capillary was thicker in the diabetic than in the nondiabetic twin [31].

6. Mechanism of Capillary Microaneurysm Formation in Diabetic Retinopathy

Retinal capillaries consist of three structures: endothelial cells (E), basement membrane (BM), and intramural pericytes (IMP), which are located within the BM. IMP is present in the normal retina at a ratio of approximately 1 with E. Retinal microaneurysms are among the earliest visible lesions in the diabetic retina, consisting of a unilateral outpunching on the venous part of the capillaries or small venules, and particularly aggregated in the posterior polar region of the retina. Ballantyne and Loewenstein [32] made the observation that the microaneurysms are usually observed only in the two-dimensional, close-knit network of capillaries of the inner-nuclear layer. The mechanism of microaneurysm formation in diabetic retinopathy may presuppose one or more of the following factors: (1) a focal structural weakness in the vessel wall, (2) an increased hydrostatic back pressure, and (3) a focal endothelial cell proliferation. In regard to (1) a focal weakness in the vessel wall may be produced by accelerated endothelial cell death and loss of intramural pericytes. For (2) and (3) Williamson and Kilo [31], Ashton [33], and Ballantyne [34] considered that microaneurysms were caused by a chronic condition of stasis on the venous side of the retinal circulation. Such stasis would logically be produced to a greater degree in the deeper close-knit network of capillaries in the inner nuclear layer, which offer more resistance than those in the superficial plexus of the retina in venous circulatory impairment. Many ophthalmologists have been impressed by the finding of considerable venular congestion and distension prior to or simultaneous to the development of microaneurysms, particularly in young diabetics. Jutte [35] carefully measured the retinal veins and found dilations in 43 of 100 juvenile diabetics. Jutte, as well as Thiel [36], observed that the dilatation extended into the small venules and venous part of capillaries. Skovborg et al. [37] measured vessel diameters in the retina from the negatives of retinal photographs of 346 juvenile diabetics and 146 healthy subjects. The average venous diameter was 10% wider in diabetic patients than in the controls (P < 0.001). In diabetes, both hypophosphatemia and glycosylation of hemoglobin to HbA1c, which has increased oxygen affinity, lead to a slight left shift in the oxyhemoglobin dissociation curve that impairs oxygen release to the venous part of the microcirculation [6]. Venous dilatation (lack of tone) without associated arteriolar dilatation gives rise to a sluggish venous blood flow. With a decreasing shear rate in flow in the dilated venous microcirculation, hemorheological changes in the form of erythrocyte aggregation and blood viscosity (due to increased concentration of plasma fibrinogen and [alpha.sub.2] globulin) are aggravated [38] and further decrease venous blood flow and increase hydrostatic back pressure, leading to stagnant hypoxia. This static condition can extend into the two-dimensional, close-knit network of capillaries of the inner nuclear layer. Increased endothelium proliferation, probably caused by IMP death, may also occur [39, 40]. Capillary remodeling during stasis, increased hydrostatic pressure, hypoxia, and local endothelium proliferation could be the mechanism for retinal microaneurysm formation. Microaneurysms are only one variety of ecstasies that occur in the retinal capillaries. Sometimes relatively long segments are so dilated they form sausage-shaped loops, as shown by Ballantyne and Loewenstein [32] who described microaneurysms derived from such varicose loops.

7. Vascular Aging in Heath and Diabetes

Thickening of BM also occurs with age in healthy persons but is far more common and severe in diabetes patients of similar ages. However, comparison of the macro- and microvascular lesions in diabetes with those of normal aging show morphologic similarities to such a degree that common pathogenetic mechanisms must be considered [8].

Atherosclerosis in the diabetic population tends to occur at an earlier age and with greater severity than in the nondiabetic population. Until now, there has been no convincing qualitative difference between atherosclerosis in diabetics and nondiabetics [41]. "Blinded" morpho-metric/biomicroscopic studies of small blood vessels (arterioles, capillaries, and venules) in an asymptomatic surface area (bulbar conjunctiva) of diabetic and healthy persons of various ages also showed degenerative changes at an earlier age and to more significant degrees in diabetic patients compared with controls [42]. Other than age, diabetic patients showed changes more characteristic of, but not specific to, the disease, including tortuous elongation of venous capillaries, elongation and distension of the venules extending into the venous capillaries, markedly decreased linear rate of venular blood flow, and evidence of increased plasma permeability. Rabini et al. [43] studied ATP content in human erythrocytes during aging in healthy and diabetic subjects and found a significant negative correlation between age and red cell ATP in healthy control subjects (r = 0.82; P < 0.001). They concluded that their data indicated an aging-related reduction in the erythrocyte ATP content in both healthy and probable in Type 2 diabetic subjects. Short et al. [44] studied mitochondrial ATP production in skeletal muscles during aging in 146 healthy men and women aged 18-89 yrs and demonstrated that muscle ATP production declined with advancing age. It has been shown that the concentration of plasma [P.sub.i] and renal tubular reabsorption of [P.sub.i] ([T.sub.mPO4]/GFR) are similarly closely related to age and gender, with the highest values occurring in childhood. In adults, plasma [P.sub.i] in men declines with age almost linearly to the eighties, whereas, in women under the age of 45, the values overlap those of men and then increase between 45 and 54 years before declining thereafter [45].

Thus, during aging, hypophosphatemia may also be associated with a decreasing amount of intracellular tissue ATP.

8. Comments

The present paper stresses the importance of lack of high energy phosphate (ATP) and hypoxia in the pathogenesis of diabetic retinopathy. This hypothesis may be strengthened by the finding that lifestyle diseases and cardiovascular risk factors are similarly associated with deficiencies of major substrates in ATP synthesis, that is, hypophosphatemia and/or lack of oxygen. Age, male gender, hypertension, obesity, metabolic syndrome, and diabetes mellitus are all associated with hypophosphatemia. In addition, smoking, hyperchylomicronemia, hypertension, and diabetes may involve defects in tissue oxygen delivery [8]. Two potential risk factors, infectious diseases and stress, may be added. Haglin et al. [46] reviewed 967 patients (449 women and 518 men) treated in 1993 at the Department of Infectious Diseases, Umea University, Sweden. Of those, 402 (42%) showed hypophosphatemia at admission and a multiple logistic regression showed a 4-fold higher risk of low serum phosphate in patients with severe infections. Although stress is difficult to define, it is generally considered as a physical, mental, or emotional strain or tension with fight-or-flight response resulting in the release of catecholamines, especially epinephrine (adrenaline). Epinephrine is a known hypophosphatemic hormone in man [47]. The remarkably close correlation found by Lichtman and coworkers between hypophosphatemia and erythrocyte ATP [9] and its association to life style diseases and many cardiovascular risk factors makes it tempting to call hypophosphatemia "the silent killer"

Figure 1 illustrates the concept that risk factors for cardiovascular diseases lead to mitochondrial dysfunction due to lack of intracellular phosphate and/or hypoxia.

As plasma phosphate levels decrease with age and vital tissues cannot produce sufficient ATP, the mechanism ceases to function. Like a car without gasoline, life ends when tissues cannot make sufficient ATP.

The retina has the highest oxygen demand of any tissue [48] and is therefore dependent on optimal tissue oxygen delivery and ATP production. If the endothelial cells or/and intramural pericytes lack ATP, normal vascular tone cannot be maintained and permeability will increase. As shown in Table 1, retinal capillary microaneurysms are not specific to diabetes, having been demonstrated in a number of nondiabetic clinical disorders that, however, are all associated with some type of retinal hypoxia.

Figure 2 shows a flow chart representing the biochemical and pathophysiological changes leading to decreased oxygen availability/demand ratio in the diabetic retina. Hypoxia is present from the early stages of diabetes as affinity and static hypoxia, possibly with secretion of vascular endothelium growth factor (VEGF) and erythropoietin (EPO). Later, when capillary closure begins, hypoxia is aggravated by ischemic hypoxia. Thereafter, further secretion of VEGF and EPO, which is also considered a potent hypoxic-inducible vascular endothelial growth factor, occurs. This latter hypoxic response to reduced oxygen availability is largely mediated by hypoxia-inducible transcription factors (HIF). High local EPO concentrations in the human vitreous body have been found to be strongly associated with proliferative diabetic retinopathy [49]. Furthermore Tong et al. [50] provided interesting data suggesting that a promoter polymorphism of the EPO gene is associated with severe diabetic eye and kidney complications. Their study suggests that a genetically determined ability of EPO synthesis predisposes diabetic patients to the development of diabetic proliferative retinopathy and end-stage renal failure.

9. Potential Intervention

Many questions pertaining to therapeutic interventions remain, including whether it is possible to overcome the lack of intracellular phosphate in insulin-insensitive tissues in which the vascular sequelae develop. Several therapeutic intervention trials have been carried out, including assessment of optimal glucose regulation, the effect of dietary inclusion of calcium diphosphate, and pharmacological intake of etidronate disodium, but none wholly overcome the problem [5].

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The work was supported by Bagger-Sorensen Fonden, Det Obelske Familiefond, Herta Christensens Fond, and Fight for Sight, Denmark.

References

[1] The Diabetes Control and Complication Trial Research Group, "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus" The New England Journal of Medicine, vol. 329, no. 14, pp. 977-986, 1993.

[2] UK Prospective Diabetes Study (UKPDS) Group, "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)," The Lancet, vol. 352, no. 9131, pp. 837-853, 1998.

[3] D. E. McMillan, "Development of vascular complications in diabetes," Vascular Medicine, vol. 2, no. 2, pp. 132-142, 1997.

[4] I. Hirsch and M. Brownlee, "Beyond hemoglobin [A.sub.1c]--need for additional markers of risk for diabetic microvascular complications," The Journal of the American Medical Association, vol. 303, no. 22, pp. 2291-2292, 2010.

[5] J. Ditzel and H. H. Lervang, "Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials," Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 2, pp. 173-177, 2009.

[6] J. Ditzel and H.-H. Lervang, "Disturbance of inorganic phosphate metabolism in diabetes mellitus: its impact on the development of diabetic late complications," Current Diabetes Reviews, vol. 6, no. 5, pp. 323-333, 2010.

[7] J. Ditzel and H. H. Lervang, "Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis," Diabetes, Metabolic syndrome and Obesity: Targets and Therapy, vol. 3, pp. 319-324, 2010.

[8] J. Ditzel and H.-H. Lervang, "Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis," Vascular Health and Risk Management, vol. 6, no. 1, pp. 829-836, 2010.

[9] M. A. Lichtman, D. R. Miller, and R. B. Freeman, "Erythrocyte adenosine triphosphate depletion during hypophosphatemia in a uremic subject," The New England Journal of Medicine, vol. 280, no. 5, pp. 240-244, 1969.

[10] V. W. Dennis and P. C. Brazy, "Sodium, phosphate, glucose, bicarbonate, and alanine interactions in the isolated proximal convoluted tubule of the rabbit kidney," The Journal of Clinical Investigation, vol. 62, no. 2, pp. 387-397, 1978.

[11] P. O. Barrett and P. S. Aronson, "Glucose and alanine inhibition of phosphate transport in renal microvillus membrane vesicles," American Journal of Physiology: Renal Physiology, vol. 242, no. 2, pp. F126-F131, 1982.

[12] P. S. Aronson and B. Sacktor, "The [Na.sup.+] gradient dependent transport of D-glucose in renal brush border membranes," The Journal of Biological Chemistry, vol. 250, no. 15, pp. 6032-6039, 1975.

[13] J. Ditzel, J. Brochner-Mortensen, and R. Kawahara, "Dysfunction of tubular phosphate reabsorption related to glomerular filtration and blood glucose control in diabetic children," Diabetologia, vol. 23, no. 5, pp. 406-410, 1982.

[14] E. Farber, "ATP and cell integrity," Federation Proceedings, vol. 32, no. 4, pp. 1534-1539, 1973.

[15] S. F. Travis, H. J. Sugerman, R. Ruberg et al., "Alterations of red-cell glycolytic intermediates and oxygen transport as a consequence of hypophosphatemia in patients receiving intravenous hyperalimentation," The New England Journal of Medicine, vol. 285, no. 14, pp. 763-768, 1971.

[16] G. F. Sheldon and S. Grzyb, "Phosphate depletion and repletion: relation to parenteral nutrition and oxygen transport," Annals of Surgery, vol. 182, no. 6, pp. 683-689, 1975.

[17] M. A. Lichtman and D. R. Miller, "Erythrocyte glycolysis, 2,3-diphosphoglycerate and adenosine triphosphate concentration in uremic subjects: relationship to extracellular phosphate concentration," The Journal of Laboratory and Clinical Medicine, vol. 76, no. 2, pp. 267-279, 1970.

[18] B. Chance, J. S. Leigh Jr., and J. Kent, "Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance," Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 24, pp. 9458-9462, 1986.

[19] D. G. Cogan, D. Toussaint, and T. Kuwabara, "Retinal vascular patterns: IV Diabetic retinopathy," Archives of Ophthalmology, vol. 66, no. 3, pp. 368-378, 1961.

[20] D. G. Cogan and T. Kuwabara, "Capillary shunts in the pathogenesis of diabetic retinopathy," Diabetes, vol. 12, no. 4, pp. 283-300, 1963.

[21] A. Das, R. N. Frank, M. L. Weber, A. Kennedy, C. A. Reidy, and M. A. Mancini, "ATP causes retinal pericytes to contract in vitro" Experimental Eye Research, vol. 46, no. 3, pp. 349-362, 1988.

[22] D. J. Addison, A. Garner, and N. Ashton, "Degeneration of intramural pericytes in diabetic retinopathy," British Medical Journal, vol. 1, no. 691, pp. 264-266, 1970.

[23] P. Speiser, A. M. Gittelsohn, and A. Patz, "Studies on diabetic retinopathy. III. Influence of diabetes on intramural pericytes" Archives of Ophthalmology, vol. 80, no. 3, pp. 332-337, 1968.

[24] R. Vracko, "Skeletal muscle capillaries in diabetics. A quantitative analysis," Circulation, vol. 41, no. 2, pp. 271-283, 1970.

[25] R. Vracko, "Basal lamina layering in diabetes mellitus: evidence for accelerated rate of cell death and cell regeneration," Diabetes, vol. 23, no. 2, pp. 94-104, 1974.

[26] R. Vracko and E. P. Benditt, "Basal lamina: the scaffold for orderly cell replacement. Observations on regeneration of injured skeletal muscle fibers and capillaries," The Journal of Cell Biology, vol. 55, no. 2, pp. 406-419, 1972.

[27] M. Mizutani, T. S. Kern, and M. Lorenzi, "Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy," The Journal of Clinical Investigation, vol. 97, no. 12, pp. 2883-2890, 1996.

[28] G. M. Martin, C. A. Sprague, and C. J. Epstein, "Replicative life-span of cultivated human cells: effects of donor's age, tissue, and genotype," Laboratory Investigation, vol. 23, no. 1, pp. 86-92, 1970.

[29] R. Vracko and E. P. Benditt, "Restricted replicative life span of diabetic fibroblasts in vitro: its relation to microangiopathy," Federation Proceedings, vol. 34, no. 1, pp. 68-70, 1975.

[30] R. Vracko, "A comparison of the microvascular lesions in diabetes mellitus with those in normal aging," Journal of the American Geriatrics Society, vol. 30, no. 3, pp. 201-205, 1982.

[31] J. B. Williamson and C. Kilo, "Capillary basement membranes in diabetes," Diabetes, vol. 32, supplement 2, pp. 96-100, 1983.

[32] A. J. Ballantyne and A. Loewenstein, "Retinal micro-aneurysms and punctuate haemorrhages," The British Journal of Ophthalmology, vol. 28, no. 12, pp. 593-598, 1944.

[33] N. Ashton, "Studies of the retinal capillaries in relation to diabetic and other retinopathies," The British Journal of Ophthalmology, vol. 47, no. 9, pp. 521-538, 1963.

[34] A. J. Ballantyne, "The state of the retina in diabetes mellitus," Transactions of the Ophthalmological Societies of the United Kingdom, vol. 66, pp. 503-542, 1946.

[35] A. Jutte, "Uber die erweiterung des netzhautvenen bei junglishen diabetikern," in Diabetische Angiopatie, G. Mohnike, Ed., Akademie, Berlin, Germany, 1964.

[36] R. Thiel, Der Diabetes Mellitus, Ein Gefass-Problem?: Ein Ophthalmologischer Beitrag zur Entstehung und Art des Diabetischen Gefass-Schadens, Bucherei des Augenarztes. Bei-hefte der Klinischen Monatsblatter fur Augenheilkunde, 25, Enke, Stuttgart, Germany, 1956.

[37] F. Skovborg, A. V. Nielsen, E. Lauritzen, and O. Hartkopp, "Diameters of the retinal vessels in diabetic and normal subjects," Diabetes, vol. 18, no. 5, pp. 292-298, 1969.

[38] J. Ditzel, "Haemorheological factors in the development of diabetic microangiopathy," The British Journal of Ophthalmology, vol. 51, no. 12, pp. 793-803, 1967.

[39] E. Aguilar, M. Friedlander, and R. F. Gariano, "Endothelial proliferation in diabetic retinal microaneurysms," Archives of Ophthalmology, vol. 121, no. 5, pp. 740-741, 2003.

[40] M. Hellstrom, H. Gerhardt, M. Kalen et al., "Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis," The Journal ofCell Biology, vol. 153, no. 3, pp. 543-554, 2001.

[41] K. Pyorala, M. Laakso, and M. Uusitupa, "Diabetes and atherosclerosis: an epidemiologic view," Diabetes/Metabolism Reviews, vol. 3, no. 2, pp. 463-524, 1987.

[42] J. Ditzel, "Angioscopic changes in the smaller blood vessels in diabetes mellitus and their relationship to aging," Circulation, vol. 14, no. 3, pp. 386-397, 1956.

[43] R. A. Rabini, E. Petruzzi, R. Staffolani et al., "Diabetes mellitus and subjects' ageing: a study on the ATP content and ATP-related enzyme activities in human erythrocytes," European Journal ofClinical Investigation, vol. 27, no. 4, pp. 327-332, 1997.

[44] K. R. Short, M. L. Bigelow, J. Kahl et al., "Decline in skeletal muscle mitochondrial function with aging in humans," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 15, pp. 5618-5623, 2005.

[45] H. Cirillo, C. Ciacci, and N. G. de Santo, "Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults," The New England Journal of Medicine, vol. 359, no. 8, pp. 864-866, 2008.

[46] L. Haglin, L. A. Burman, and M. Nilsson, "High prevalence of hypophosphataemia amongst patients with infectious diseases. A retrospective study," Journal of Internal Medicine, vol. 246, no. 1, pp. 45-52, 1999.

[47] J. J. Body, P. E. Cryer, K. P. Offord, and H. Heath III, "Epinephrine is a hypophosphatemic hormone in man," The Journal ofClinical Investigation, vol. 71, no. 3, pp. 572-578, 1983.

[48] C. Kaur, W. S. Foulds, and E. A. Ling, "Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management," Progress in Retinal and Eye Research, vol. 27, no. 6, pp. 622-647, 2008.

[49] D. Watanabe, K. Suzuma, S. Matsui et al., "Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy," The New England Journal of Medicine, vol. 353, no. 8, pp. 782-792, 2005.

[50] Z. Tong, Z. Yang, S. Patel et al., "Promoter polymorphism of the erythropoietin gene in severe diabetic eye an kidney complications," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 19, pp. 6998-7003, 2008.

H. Vorum (1) and J. Ditzel (2)

(1) Department of Ophthalmology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark

(2) Department of Endocrinology, Center for Prevention of Struma and Metabolic Diseases, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark

Correspondence should be addressed to J. Ditzel; jditzel@ofir.dk

Received 1 September 2013; Accepted 11 February 2014; Published 20 March 2014

Academic Editor: Pierre Lachapelle

Copyright [c] 2014 H. Vorum and J. Ditzel. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

TABLE 1: Capillary retinal microaneurysms are found in the following
diseases, all associated with some form of hypoxia.

Disease                   Location                  Mechanism

Retinal vein occlusion    Posterior, peripheral     Stagnant hypoxia
Macroglobulinemia         Peripheral, posterior     Stagnant hypoxia
Multiple myeloma          Peripheral, posterior     Stagnant hypoxia
Sickle-cell anemia        Peripheral, posterior     Stagnant hypoxia
                                                    Ischemic hypoxia
Malignant hypertension    Peripheral, posterior     Ischemic hypoxia
Pulseless disease         Peripheral, posterior     Ischemic hypoxia
                                                    Affinity hypoxia
Diabetes mellitus         Posterior, peripheral     Stagnant hypoxia
                                                    Ischemic hypoxia
COPYRIGHT 2014 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Vorum, H.; Ditzel, J.
Publication:Journal of Ophthalmology
Article Type:Report
Date:Jan 1, 2014
Words:5402
Previous Article:Evaluation of the endothelial cell density and the central corneal thickness in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
Next Article:Long-term outcomes of rheohaemapheresis in the treatment of dry form of age-related macular degeneration.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters